Business Description
Jaguar Health is a San Francisco-based pharmaceutical company that develops plant-derived medicines to treat gastrointestinal conditions in both humans and animals. Its flagship product, Mytesi, is an approved treatment for diarrhea in HIV/AIDS patients, while Canalevia-CA1 addresses the same condition in dogs undergoing chemotherapy. The company is advancing a broader pipeline of treatments targeting conditions such as irritable bowel syndrome, short bowel syndrome, and cancer-related diarrhea across multiple clinical trials.
